Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Compagnie réclamée
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions Lire la suite
challenging, rewarding, exciting, collaborative, meaningful
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
Passion, Courage, Commitment, Intellect and Innovation
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
fast paced, constantly challenged, celebrate victories
Quelle est la meilleure partie de votre programme de rémunération?
base, bonus and equity with monthly vesting after year 1
Qu’est-ce qui vous rend le plus heureux au travail?
Moving the company, the science and the function forward every day. Putting patients first
Quelles sont les meilleures choses à propos de votre équipe?
We have each others backs and we actually care about each other as people. We also have diverse and complimentary skills.
Other Employee Reviews for Karyopharm Therapeutics
×